LamiSpine
SURGERY

The Most Finely Targeted CYTOTHERAPY
for Spinal Cord Patients (T11-L1)

Play Video

LAMINECTOMY PLUS INTRA-SPINAL INJECTION

LamiSpine is a two-step, SCI breakthrough

LamiSpine is the unique procedure designed by Unique Access Medical (UAM)
– global leader in innovative spinal cord treatments aimed at recovery.

It includes “laminectomy,” which is the removal of a small section of an SCI patient’s spine called a ”Lamina”, followed by “intra-spinal cord”  injections of patented hAFSC Cytotherapy.

The laminectomy targets the precise location of spinal cord tissue damage using the AFSCs and delivers the maximum number of impact right at the injured location

SAFETY AND EFFECTIVENESS

LamiSpine surgery is suitable for complete or incomplete spinal injury. Especially patients with injuries at T11-L1 will benefit the most. Results are measured by bodily functions regained and symptoms reduced.

Cytotherapy using hAFSCs or MSCs are increasingly popular. This is partly due to the absence of side effects, but also due to the high success rates. For SCI, it is most effective when injected as direct and as local as possible, which is the case with LamiSpine.

Laminectomy plus intra-spinal hAFSC injections allow for direct targeting of the injured spinal tissue, so people suffering the symptoms of SCI can experience improvements in motor and sensory function. You could be next to feel empowered by LamiSpine surgery!

HEAR WHAT LamiSpine PATIENTS ARE SAYING

Epidural Stimulation Case Reports

Get Free Access Now!

[wufoo username="secureupload" formhash="mjrzv2t1nkbqy9" autoresize="true" height="965" header="show" ssl="true"]